HDAC1 and hepatocellular carcinoma: The combined chemotherapy led to the inhibition of HDAC1/2 as well as changes in HCC cell morphology, growth inhibition, cell cycle blockage and apoptosis in vitro and growth suppression of subcutaneous HCC xenograft tumors in vivo [56].